Actively Recruiting
The Mycophenolate Pregnancy Registry
Led by Genentech, Inc. · Updated on 2026-05-14
500
Participants Needed
1
Research Sites
1466 weeks
Total Duration
On this page
Sponsors
G
Genentech, Inc.
Lead Sponsor
A
Accord Healthcare, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Mycophenolate Pregnancy Registry is designed as a prospective, observational registry collecting data regarding mycophenolate exposure during pregnancy, and pregnancy outcomes, fetal and infant outcomes after exposure. Early and later term pregnancy outcomes will be solicited at selected gestational time points. Structural and functional birth defects identified in the perinatal period through one year of life will be collected and classified. This is a non-proprietary registry and is a component of a comprehensive pregnancy Risk Evaluation and Mitigation Strategy (REMS) plan required by the FDA for all mycophenolate-formulations, including CellCept, Myfortic and any generic formulations.
CONDITIONS
Official Title
The Mycophenolate Pregnancy Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnancy and reported maternal exposure to mycophenolate during pregnancy or within 6 weeks of discontinuing treatment
You will not qualify if you...
- Pregnancies with only paternal exposure to mycophenolate
- Pregnancies occurring outside the United States
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Quintiles Outcome
Cambridge, Massachusetts, United States, 02139
Actively Recruiting
Research Team
R
Reference Study ID Number: ML22679 https://forpatients.roche.com/
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here